US dealmaking has suffered its worst start to a year in a decade after policy volatility following Donald Trump’s election and escalating rhetoric over tariffs put a sudden chill on activity.

Clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis—Sionna Therapeutics (SION) priced its upsized initial public offering of ...

Maybank Securities’ Thilan Wickramasinghe hiked his target price to $14.16 from $10.12, but RHB Bank Singapore’s Shekhar ...

Titan America has raised $384 million after pricing its U.S. initial public offering at $16 per share, within its targeted ...

The FPX ETF, focused on high-growth IPOs, may not be the best investment choice in a high-interest rate environment. Read an analysis here.

The exchange maintained its position as the second-largest bourse in the region and reinforced its ranking among the world's ...

Titan America SA and its owner Titan Cement International SA raised $384 million in an initial public offering, pricing its ...

Titan America SA (“Titan America”), a subsidiary of Titan Cement International SA and parent company of its U.S. operations, ...

Hexaware, majority owned by private equity firm Carlyle Group, has filed revised papers to launch a ₹8,750 crore IPO, lower ...

The promoter initially planned to raise $1.2 billion when it had filed for regulatory approval in September. The size of ...

Cameron and Tyler Winklevoss’ crypto company, Gemini, is planning to hit the stock market, according to a report from ...

Stock Market LIVE Updates | Indian markets closed with little change on Wednesday as investors adopted a cautious approach ...